Change in dietary inflammatory index score is associated with control of long-term rheumatoid arthritis disease activity in a Japanese cohort: the TOMORROW study.


Journal

Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438

Informations de publication

Date de publication:
08 04 2021
Historique:
received: 27 09 2020
accepted: 12 03 2021
entrez: 9 4 2021
pubmed: 10 4 2021
medline: 22 6 2021
Statut: epublish

Résumé

The dietary inflammatory index (DII®), a quantitative measure of the inflammatory potential of daily food and nutrient intake, and associations between a variety of health outcomes have been reported. However, the association between DII score and disease activity of rheumatoid arthritis (RA) is unclear. Therefore, this study was designed to test whether higher DII score contributes to disease activity and as a corollary, whether reducing DII score helps to achieve or maintain low disease activity or remission in patients with RA. We performed a cross-sectional and longitudinal analysis using 6 years of data (from 2011 to 2017) in TOMORROW, a cohort study consisting of 208 RA patients and 205 gender- and age-matched controls started in 2010. Disease activity of RA patients was assessed annually using DAS28-ESR (disease activity score 28 joints and the erythrocyte sedimentation rate) as a composite measure based on arthritic symptoms in 28 joints plus global health assessment and ESR. Dietary data were collected in 2011 and 2017 using the brief-type self-administered diet history questionnaire (BDHQ). Energy-adjusted DII (E-DII™) score was calculated using 26 nutrients derived from the BDHQ. Data were analyzed with two-group comparisons, correlation analysis, and multivariable logistic regression analysis. One hundred and seventy-seven RA patients and 183 controls, for whom clinical and dietary survey data were available, were analyzed. RA patients had significantly higher E-DII (pro-inflammatory) score compared to controls both in 2011 and 2017 (p < 0.05). In RA patients, E-DII score was not a factor associated with significant change in disease activity. However, anti-inflammatory change in E-DII score was associated maintaining low disease activity (DAS28-ESR ≤ 3.2) or less for 6 years (OR 3.46, 95% CI 0.33-8.98, p = 0.011). The diets of RA patients had a higher inflammatory potential than controls. Although E-DII score was not a factor associated with significant disease activity change, anti-inflammatory change in E-DII score appeared to be associated with maintaining low disease activity in patients with RA. UMIN Clinical Trials Registry, UMIN000003876 . Registered 7 Aug 2010-retrospectively registered.

Sections du résumé

BACKGROUND
The dietary inflammatory index (DII®), a quantitative measure of the inflammatory potential of daily food and nutrient intake, and associations between a variety of health outcomes have been reported. However, the association between DII score and disease activity of rheumatoid arthritis (RA) is unclear. Therefore, this study was designed to test whether higher DII score contributes to disease activity and as a corollary, whether reducing DII score helps to achieve or maintain low disease activity or remission in patients with RA.
METHODS
We performed a cross-sectional and longitudinal analysis using 6 years of data (from 2011 to 2017) in TOMORROW, a cohort study consisting of 208 RA patients and 205 gender- and age-matched controls started in 2010. Disease activity of RA patients was assessed annually using DAS28-ESR (disease activity score 28 joints and the erythrocyte sedimentation rate) as a composite measure based on arthritic symptoms in 28 joints plus global health assessment and ESR. Dietary data were collected in 2011 and 2017 using the brief-type self-administered diet history questionnaire (BDHQ). Energy-adjusted DII (E-DII™) score was calculated using 26 nutrients derived from the BDHQ. Data were analyzed with two-group comparisons, correlation analysis, and multivariable logistic regression analysis.
RESULTS
One hundred and seventy-seven RA patients and 183 controls, for whom clinical and dietary survey data were available, were analyzed. RA patients had significantly higher E-DII (pro-inflammatory) score compared to controls both in 2011 and 2017 (p < 0.05). In RA patients, E-DII score was not a factor associated with significant change in disease activity. However, anti-inflammatory change in E-DII score was associated maintaining low disease activity (DAS28-ESR ≤ 3.2) or less for 6 years (OR 3.46, 95% CI 0.33-8.98, p = 0.011).
CONCLUSIONS
The diets of RA patients had a higher inflammatory potential than controls. Although E-DII score was not a factor associated with significant disease activity change, anti-inflammatory change in E-DII score appeared to be associated with maintaining low disease activity in patients with RA.
TRIAL REGISTRATION
UMIN Clinical Trials Registry, UMIN000003876 . Registered 7 Aug 2010-retrospectively registered.

Identifiants

pubmed: 33832530
doi: 10.1186/s13075-021-02478-y
pii: 10.1186/s13075-021-02478-y
pmc: PMC8028141
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105

Références

Ann Rheum Dis. 2016 Jan;75(1):3-15
pubmed: 25969430
Am J Epidemiol. 2007 Mar 15;165(6):710-8
pubmed: 17182981
Mod Rheumatol. 2017 Jan;27(1):8-14
pubmed: 27142648
Ann Rheum Dis. 2007 Sep;66(9):1239-43
pubmed: 17613557
Adv Nutr. 2019 Mar 1;10(2):185-195
pubmed: 30615051
BMC Rheumatol. 2020 Mar 10;4:10
pubmed: 32175525
Arthritis Rheum. 1996 Jan;39(1):34-40
pubmed: 8546736
Nutrients. 2017 Sep 20;9(9):
pubmed: 28930191
Arthritis Care Res (Hoboken). 2020 Mar;72(3):301-308
pubmed: 30891938
Arthritis Rheum. 1998 Oct;41(10):1845-50
pubmed: 9778226
J Nutr. 2017 Mar;147(3):430-438
pubmed: 28179489
Ann Rheum Dis. 2020 Jun;79(6):685-699
pubmed: 31969328
Am J Clin Nutr. 2017 Jun;105(6):1399-1407
pubmed: 28424183
J Hum Nutr Diet. 2003 Apr;16(2):97-109
pubmed: 12662368
Clin Nutr. 2020 Jan;39(1):185-191
pubmed: 30737049
Curr Opin Clin Nutr Metab Care. 2001 Mar;4(2):115-21
pubmed: 11224655
Clin Nutr. 2018 Apr;37(2):675-680
pubmed: 28285975
J Epidemiol. 2012;22(2):151-9
pubmed: 22343326
J Med Food. 2017 Oct;20(10):1022-1030
pubmed: 28850308
Mod Rheumatol. 2015 Mar;25(2):246-50
pubmed: 25211403
Ann Rheum Dis. 2017 Aug;76(8):1357-1364
pubmed: 28137914
Int J Cancer. 2017 Dec 1;141(11):2215-2227
pubmed: 28795402
Ann Rheum Dis. 1990 Nov;49(11):916-20
pubmed: 2256738
J Nutr Gerontol Geriatr. 2019 Jan-Mar;38(1):18-32
pubmed: 30849025
Int J Cancer. 2017 Feb 1;140(3):535-543
pubmed: 27727481
J Am Diet Assoc. 2010 May;110(5):727-35
pubmed: 20430134
Clin Rheumatol. 2019 Jan;38(1):243-250
pubmed: 30109509
Arthritis Rheum. 1983 Nov;26(11):1346-53
pubmed: 6639693
Nutrition. 2019 Jul - Aug;63-64:205-210
pubmed: 31029049
Open Rheumatol J. 2018 Feb 08;12:19-28
pubmed: 29515679
Public Health Nutr. 2011 Jul;14(7):1200-11
pubmed: 21477414
J Nutr Health Aging. 2019;23(4):323-329
pubmed: 30932130
Horm Metab Res. 2018 May;50(5):345-358
pubmed: 29723899
Public Health Nutr. 2014 Aug;17(8):1689-96
pubmed: 23941862
Am J Clin Nutr. 2020 Jun 1;111(6):1203-1213
pubmed: 32055820
Ann Rheum Dis. 2003 Mar;62(3):208-14
pubmed: 12594104

Auteurs

Yoshinari Matsumoto (Y)

Shirahama Foundation for Health and Welfare, Search Institute for Bone and Arthritis Disease (SINBAD), Nishimuro-gun, Shirahama-cho 1447, Wakayama, 649-2211, Japan.
Department of Medical Nutrition, Osaka City University Graduate School of Human Life Science, Sumiyoshi-ku, Sugimoto-cho 3-3-138, Osaka, 558-8585, Japan.

Nitin Shivappa (N)

Cancer Prevention and Control Program and Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 915 Greene Street, Suite 241-2, Columbia, SC, 29208, USA.
Department of Nutrition, Connecting Health Innovations LLC, 1417 Gregg St., Columbia, SC, 29201, USA.

Yuko Sugioka (Y)

Center for Senile Degenerative Disorders (CSDD), Osaka City University Medical School, Abeno-ku, Asahimachi 1-4-3, Osaka, 545-8585, Japan.

Masahiro Tada (M)

Departments of Orthopaedic Surgery, Osaka City University Medical School, Abeno-ku, Asahimachi 1-4-3, Osaka, 545-8585, Japan.

Tadashi Okano (T)

Departments of Orthopaedic Surgery, Osaka City University Medical School, Abeno-ku, Asahimachi 1-4-3, Osaka, 545-8585, Japan.

Kenji Mamoto (K)

Departments of Orthopaedic Surgery, Osaka City University Medical School, Abeno-ku, Asahimachi 1-4-3, Osaka, 545-8585, Japan.

Kentaro Inui (K)

Departments of Orthopaedic Surgery, Osaka City University Medical School, Abeno-ku, Asahimachi 1-4-3, Osaka, 545-8585, Japan.

Daiki Habu (D)

Department of Medical Nutrition, Osaka City University Graduate School of Human Life Science, Sumiyoshi-ku, Sugimoto-cho 3-3-138, Osaka, 558-8585, Japan.

James R Hebert (JR)

Cancer Prevention and Control Program and Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 915 Greene Street, Suite 241-2, Columbia, SC, 29208, USA.
Department of Nutrition, Connecting Health Innovations LLC, 1417 Gregg St., Columbia, SC, 29201, USA.

Tatsuya Koike (T)

Shirahama Foundation for Health and Welfare, Search Institute for Bone and Arthritis Disease (SINBAD), Nishimuro-gun, Shirahama-cho 1447, Wakayama, 649-2211, Japan. tatsuya@med.osaka-cu.ac.jp.
Center for Senile Degenerative Disorders (CSDD), Osaka City University Medical School, Abeno-ku, Asahimachi 1-4-3, Osaka, 545-8585, Japan. tatsuya@med.osaka-cu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH